Benign neoplasm of mesothelial tissue
In Benign neoplasms, except benign neuroendocrine tumors (D10-D36), chapter 2: Neoplasms
4 billable codes under D19: none are a CC or MCC; none map to an HCC.
Advertisements
Official coding guidelines
From the ICD-10-CM Official Guidelines for Coding and Reporting, FY 2027 (CMS and NCHS). Links open the PDF at the right page.
Rules for coding benign and malignant neoplasms: using the Neoplasm Table, sequencing primary and secondary sites, treatment encounters, complications, and current cancer versus personal history.
- Admission/Encounter for treatment of primary site (page 33)
- Admission/Encounter for treatment of secondary site (page 33)
- Coding and sequencing of complications (page 34)
- Primary malignancy previously excised (page 34)
- Admissions/Encounters involving antineoplastic chemotherapy, immunotherapy and radiation therapy (page 35)
- Admission/encounter to determine extent of malignancy (page 36)
- Symptoms, signs, and abnormal findings listed in Chapter 18 associated with neoplasms (page 36)
- Admission/encounter for pain control/management (page 36)
All codes under D19
D19 can't be used on a claim. Pick a billable code below; grey headings group them.
D19 MS-DRGs
As the principal diagnosis, the billable codes under D19 group to these 14 MS-DRGs (v44.0). Which one applies depends on procedures performed, secondary diagnoses (CC/MCC), and the patient's age and discharge status.
- DRG 826 Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Major O.R. Procedures with MCC (2 of 4 codes)
- DRG 827 Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Major O.R. Procedures with CC (2 of 4 codes)
- DRG 828 Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Major O.R. Procedures without CC/MCC (2 of 4 codes)
- DRG 829 Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Other Procedures with CC/MCC (2 of 4 codes)
- DRG 830 Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Other Procedures without CC/MCC (2 of 4 codes)
- DRG 843 Other Myeloproliferative Disorders or Poorly Differentiated Neoplastic Diagnoses with MCC (2 of 4 codes)
- DRG 844 Other Myeloproliferative Disorders or Poorly Differentiated Neoplastic Diagnoses with CC (2 of 4 codes)
- DRG 845 Other Myeloproliferative Disorders or Poorly Differentiated Neoplastic Diagnoses without CC/MCC (2 of 4 codes)
- DRG 180 Respiratory Neoplasms with MCC (1 of 4 codes)
- DRG 181 Respiratory Neoplasms with CC (1 of 4 codes)
- DRG 182 Respiratory Neoplasms without CC/MCC (1 of 4 codes)
- DRG 393 Other Digestive System Diagnoses with MCC (1 of 4 codes)
- DRG 394 Other Digestive System Diagnoses with CC (1 of 4 codes)
- DRG 395 Other Digestive System Diagnoses without CC/MCC (1 of 4 codes)
Other codes that refer to D19
Notes on these codes point to D19.
About the condition
Plain-language background from MedlinePlus (National Library of Medicine), not coding guidance.
Benign Tumors
Tumors are abnormal growths in your body. They can be either benign or malignant. Benign tumors aren't cancer. Malignant ones are. Benign tumors grow only in one place. They cannot spread or invade other parts of your body. Even so, they can be dangerous if they press on vital organs, such as your brain.
Read more about benign tumors on MedlinePlusCode history
Valid since FY2016, when ICD-10-CM took effect on October 1, 2015. No changes since.